CERES BRAIN Therapeutics
Innovative creatine brain treatment
- B2B
About CERES BRAIN Therapeutics
Development of creatine-based therapies targeting cerebral diseases like Creatine Transporter Deficiency and ALS, with preclinical success and clinical progress.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2019
- Revenue
- $4.5M – $25.9MTamtam estimate
- Website
- ceres-brain.com
CERES BRAIN Therapeutics at a glance
CERES BRAIN Therapeutics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Paris, Île-de-France, France.
CERES BRAIN Therapeutics was founded in 2019.
CERES BRAIN Therapeutics has 11–50 employees.
CERES BRAIN Therapeutics's revenue is $4.5M – $25.9M (Tamtam estimate).
Selling to companies like CERES BRAIN Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies